Actively helping customers, employees and the global community during the coronavirus SARS-CoV-2 outbreak.  Learn more >>

DCFH-DA [2',7'-Dichlorodihydrofluorescein diacetate] *CAS 4091-99-0*

Chemical structure for DCFH-DA [2',7'-Dichlorodihydrofluorescein diacetate] *CAS 4091-99-0*
Chemical structure for DCFH-DA [2',7'-Dichlorodihydrofluorescein diacetate] *CAS 4091-99-0*
Ordering information
Price ()
Catalog Number15204
Unit Size
Find Distributor
Additional ordering information
Telephone1-408-733-1055
Fax1-408-733-1304
Emailsales@aatbio.com
InternationalSee distributors
ShippingStandard overnight for United States, inquire for international
Physical properties
Molecular weight487.29
SolventDMSO
Spectral properties
Excitation (nm)505
Emission (nm)526
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
UNSPSC12352200

OverviewpdfSDSpdfProtocol


CAS
4091-99-0
Molecular weight
487.29
Excitation (nm)
505
Emission (nm)
526
DCFH-DA, 2',7'-Dichlorodihydrofluorescein diacetate (also called 2',7'-dichlorofluorescin diacetate), is hydrolyzed by cellular esterases to 2',7'-dichlorodihydrofluorescein (also called 2',7'-dichlorofluorescin) and is then oxidized to 2',7'-dichlorofluorescein primarily by H2O2. 2',7'-dichlorodihydrofluorescein diacetate might be reactive toward a broad range of oxidizing reactions that may be increased during intracellular oxidant stress. This probe is widely used to monitoring cellular redox processes.

Platform


Fluorescence microscope

ExcitationFITC filter set
EmissionFITC filter set
Recommended plateBlack wall/clear bottom
Instrument specification(s)FITC filter set

Example protocol


PREPARATION OF STOCK SOLUTION

Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles.

2',7'-Dichlorodihydrofluorescein diacetate stock solution:
Make working solution in the concentration range of 1-10 mM in DMSO. Note: The unused DMSO stock solution should be aliquoted into a single use vial and stored at -20 °C. Keep from light.

PREPARATION OF WORKING SOLUTION

2',7'-Dichlorodihydrofluorescein diacetate working solution:
Make working solution in the concentration range of 1-10 µM in a physiological buffer such as PBS, HBSS, HEPES buffers. Note: The optimal working concentration for your application must be empirically determined.

SAMPLE EXPERIMENTAL PROTOCOL

The following procedures provide a general guideline and should be modified for your particular application.

  1. Remove cells from growth media, add the dye working solution to the cells, and incubate the cells at room temperature or 37oC for 5 to 60 minutes.

  2. Remove the dye working solution; wash with pre-warmed HBSS, and add pre-warmed HBSS or growth medium and incubate at the optimal temperature. The optimal recovery time can vary widely, as some cell types normally exhibit low levels of esterase activity.

  3. Determine the baseline fluorescence intensity of a sample of the loaded cells prior to exposing the cells to experimental inducements. 6. Negative controls should be assessed as follows:

  4. Examine unstained cells for autofluorescence in the green emission range.

  5. For flow cytometry, ascertain that the forward and side scatter of cells is unchanged after dye-loading and treatment. Changes in cell dimensions may be related to blebbing or shrinkage resulting from handling or a toxic response.

  6. Examine the fluorescence of cell-free mixtures of dye and buffer/media with and without the inducer. In the absence of extracellular esterases and other oxidative enzymes, the gradual increase in fluorescence over time may be related to spontaneous hydrolysis, atmospheric oxidation, and/or light-induced oxidation.

  7. Examine the fluorescence of untreated (control) loaded cells that have been maintained in growth medium or simple buffer. In healthy cells, oxygen radicals are eliminated by cellular enzymes and/or natural antioxidants. Following the dye-loading recovery period, healthy cells should exhibit a low level of fluorescence that is relatively stable for the duration of the experiment; however, a gradual increase (due to auto-oxidation) or decrease (due to loss of dye from cells or photobleaching) in fluorescence may be observed. In the absence of any stimulus or inducement, a burst of fluorescence in healthy, untreated cells could indicate progress to cell death or some other oxidative event.

  8. Positive controls may be stimulated with H2O2 or tert-butyl hydroperoxide (TBHP) to a final concentration of ~100 µM (increase or decrease dose based on the sensitivity and response of the cells).

Calculators


Common stock solution preparation

Table 1. Volume of DMSO needed to reconstitute specific mass of DCFH-DA [2',7'-Dichlorodihydrofluorescein diacetate] *CAS 4091-99-0* to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.

0.1 mg0.5 mg1 mg5 mg10 mg
1 mM205.217 µL1.026 mL2.052 mL10.261 mL20.522 mL
5 mM41.043 µL205.217 µL410.433 µL2.052 mL4.104 mL
10 mM20.522 µL102.608 µL205.217 µL1.026 mL2.052 mL

Molarity calculator

Enter any two values (mass, volume, concentration) to calculate the third.

Mass (Calculate)Molecular weightVolume (Calculate)Concentration (Calculate)Moles
/=x=

Spectrum


Open in Advanced Spectrum Viewer
spectrum

Spectral properties

Excitation (nm)505
Emission (nm)526

Citations


View all 9 citations: Citation Explorer
Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy
Authors: Wang, Tingting and Zhang, Hao and Qiu, Weibao and Han, Yaobao and Liu, Hanghang and Li, Zhen
Journal: Bioactive Materials (2022)
Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers
Authors: Sun, Qi and Yang, Zhenzhen and Lin, Meng and Peng, Yiwei and Wang, Rudong and Du, Yitian and Zhou, Yu and Li, Jiajia and Qi, Xianrong
Journal: Biomaterials (2021): 120648
Down--regulating miR-217-5p Protects Cardiomyocytes against Ischemia/Reperfusion Injury by Restoring Mitochondrial Function via Targeting SIRT1
Authors: Qi, Yujuan and Zhang, Kai and Li, Peijun and Wu, Zhenhua
Journal: Inflammation (2020): 1--14
16-Hydroxycleroda-3, 13-dien-15, 16-olide induces apoptosis in human bladder cancer cells through cell cycle arrest, mitochondria ROS overproduction, and inactivation of EGFR-related signalling pathways
Authors: Chen, Yu-Chi and Wang, Po-Yu and Huang, Bu-Miin and Chen, Yu-Jen and Lee, Wei-Chang and Chen, Yung-Chia
Journal: Molecules (2020): 3958
HIF-1$\alpha$/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells
Authors: Cui, Peng and Zhang, Ping and Zhang, Yanmin and Sun, Lihua and Cui, Guanghui and Guo, Xin and Wang, He and Zhang, Xiaowei and Shi, Yu and Yu, Zhendong
Journal: The FASEB Journal (2020): 5740--5753
Albumin-Based Nanotheranostic Probe with Hypoxia Alleviating Potentiates Synchronous Multimodal Imaging and Phototherapy for Glioma
Authors: Yang, Zhenzhen and Du, Yitian and Sun, Qi and Peng, Yiwei and Wang, Rudong and Zhou, Yu and Wang, Yuqi and Zhang, Chunli and Qi, Xianrong
Journal: ACS nano (2020): 6191--6212
Boosting H2O2-Guided Chemodynamic Therapy of Cancer by Enhancing Reaction Kinetics through Versatile Biomimetic Fenton Nanocatalysts and the Second Near-Infrared Light Irradiation
Authors: Wang, Tingting and Zhang, Hao and Liu, Hanghang and Yuan, Qiang and Ren, Feng and Han, Yaobao and Sun, Qiao and Li, Zhen and Gao, Mingyuan
Journal: Advanced Functional Materials (2019): 1906128
Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid
Authors: Lennicke, Claudia and Rahn, Jette and Bukur, J{\"u}rgen and Hochgr{\"a}fe, Falko and Wessjohann, Ludger A and Lichtenfels, Rudolf and Seliger, Barbara
Journal: Oncoimmunology (2017): e1259049

References


View all 11 references: Citation Explorer
Mitochondrial localization of reactive oxygen species by dihydrofluorescein probes
Authors: Diaz G, Liu S, Isola R, Diana A, Falchi AM.
Journal: Histochem Cell Biol (2003): 319
Kinetic analysis of fluorescein and dihydrofluorescein effluxes in tumour cells expressing the multidrug resistance protein, MRP1
Authors: Saengkhae C, Loetchutinat C, Garnier-Suillerot A.
Journal: Biochem Pharmacol (2003): 969
Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123
Authors: Hempel SL, Buettner GR, O'Malley YQ, Wessels DA, Flaherty DM.
Journal: Free Radic Biol Med (1999): 146
A rapid diagnostic test for the viability of early cattle and rabbit embryos using diacetyl-fluorescin
Authors: Schilling E, Dopke HH.
Journal: Naturwissenschaften (1978): 658
Determination of fluorescin sodium in ophthalmic solutions
Authors: Robertson EJ, Patel JA.
Journal: Am J Hosp Pharm (1968): 598
Experimental research on insulin antibodies. III. Immunohistology of the endocrine pancreas with guinea pig anti-bovine insulin serum, conjugated with fluorescin isothiocyanate.
Authors: Costanzi G, Mancini UM, Zampa GA.
Journal: Boll Soc Ital Biol Sper (1961): 1233
Experimental research on insulin antibodies. II. Immunochemical characterization of guinea pig anti-ox insulin serum conjugated with fluorescin isothiocyanate.
Authors: Mancini AM, Zampa GA, Costanzi G.
Journal: Boll Soc Ital Biol Sper (1961): 1230
Two simple media for the demonstration of pyocyanin and fluorescin
Authors: King EO, Ward MK, Raney DE.
Journal: J Lab Clin Med (1954): 301
Influence of the concentration of iron on the production of fluorescin by Pseudomonas aeruginosa
Authors: Totter JR, Moseley FT.
Journal: J Bacteriol (1953): 45
Determination of circulation time with fluorescin in normal children and in congenital or acquired cardiopathy.
Authors: Bulgarelli R, Garioni F.
Journal: Minerva Pediatr (1952): 576